C. Falato

发表论文 42 篇 · 总被引 448 次 · h-index 13

代表论文

• Clinical implications of the intrinsic molecular subtypes in hormone receptor-positive and HER2-negative metastatic breast cancer. (2022 · Cancer Treatment Reviews · 被引 59)
• Patritumab Deruxtecan in Untreated Hormone Receptor-Positive/HER2-Negative Early Breast Cancer: Final Results from Part A of the Window-of-Opportunity SOLTI TOT-HER3 Pre-Operative Study. (2023 · Annals of Oncology · 被引 37)
• Patritumab deruxtecan in HER2-negative breast cancer: part B results of the window-of-opportunity SOLTI-1805 TOT-HER3 trial and biological determinants of early response (2024 · Nature Communications · 被引 25)
• Minimally important differences for the EORTC QLQ-C30 in prostate cancer clinical trials (2021 · BMC Cancer · 被引 22)
• A 14-gene B-cell immune signature in early-stage triple-negative breast cancer (TNBC): a pooled analysis of seven studies (2024 · EBioMedicine · 被引 21)
• Oncolytic viruses: A new immunotherapeutic approach for breast cancer treatment? (2022 · Cancer Treatment Reviews · 被引 20)